| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $19.98M | - | |
| CEO | 1.74M | $10.53M | -41,666 | |
| Other | 409.9K | $2.48M | - | |
| CFO | 409.1K | $2.47M | - | |
| Other | 339.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sale+OE | 27,171 | $6.10 | $165,743.10 | -15.0% | -14.9% | -12.9% | |
| Nov 4, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sale+OE | 27,172 | $5.95 | $161,673.40 | -15.0% | -10.2% | -4.9% | |
| Oct 28, 2024 | Raab Michael56 | President &CEO | Sale+OE | 25,000 | $5.91 | $147,740.00 | -2.0% | -7.3% | -13.4% | |
| Oct 11, 2024 | Raab Michael56 | President &CEO | Sell | 7,500 | $6.01 | $45,075.00 | -0.6% | -16.1% | -18.2% | |
| Sep 27, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sell | 49,564 | $6.92 | $342,982.88 | -14.1% | -27.7% | -16.7% | |
| Sep 26, 2024 | Raab Michael56 | President &CEO | Sell | 3,000 | $6.07 | $18,210.00 | -0.2% | -24.4% | -12.9% | |
| Sep 13, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sell | 5,312 | $6.26 | $33,253.65 | -3.3% | -17.0% | +4.8% | |
| Sep 11, 2024 | Raab Michael56 | President &CEO | Sale+OE | 35,000 | $5.61 | $196,399.00 | -2.8% | -11.6% | +12.1% | |
| Aug 27, 2024 | Raab Michael56 | President &CEO | Sell | 7,500 | $6.22 | $46,635.00 | -0.6% | -15.6% | -0.5% | |
| Aug 20, 2024 | Williams Laura A55 | Chief Medical Officer | Sell | 7,412 | $5.86 | $43,436.54 | -2.3% | -19.0% | -2.1% |